EMAIL THIS PAGE TO A FRIEND

Molecular and cellular biology

Lysine Acetylation of CREBH Regulates Fasting-Induced Hepatic Lipid Metabolism.


PMID 26438600

Abstract

Cyclic AMP-responsive element-binding protein 3-like 3, hepatocyte specific (CREBH), is a hepatic transcription factor that functions as a key regulator of energy homeostasis. Here, we defined a regulatory CREBH posttranslational modification process, namely, lysine-specific acetylation, and its functional involvement in fasting-induced hepatic lipid metabolism. Fasting induces CREBH acetylation in mouse livers in a time-dependent manner, and this event is critical for CREBH transcriptional activity in regulating hepatic lipid homeostasis. The histone acetyltransferase PCAF-mediated acetylation and the deacetylase sirtuin-1-mediated deacetylation coexist to maintain CREBH acetylation states under fasting conditions. Site-directed mutagenesis and functional analyses revealed that the lysine (K) residue at position 294 (K294) within the bZIP domain of the CREBH protein is the site where fasting-induced acetylation/deacetylation occurs. Introduction of the acetylation-deficient (K294R) or acetylation-mimicking (K294Q) mutation inhibited or enhanced CREBH transcriptional activity, respectively. Importantly, CREBH acetylation at lysine 294 was required for the interaction and synergy between CREBH and peroxisome proliferator-activated receptor α (PPARα) in activating their target genes upon fasting or glucagon stimulation. Introduction of the CREBH lysine 294 mutation in the liver leads to hepatic steatosis and hyperlipidemia in animals under prolonged fasting. In summary, our study reveals a molecular mechanism by which fasting or glucagon stimulation modulates lipid homeostasis through acetylation of CREBH.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

660124
4,4′-Bis(N-carbazolyl)-1,1′-biphenyl, 97%
C36H24N2
699195
4,4′-Bis(N-carbazolyl)-1,1′-biphenyl, sublimed grade, 99.9% trace metals basis
C36H24N2
SAB2502100
Anti-LMNB1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB2502101
Anti-LMNB1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB2101352
Anti-LMNB1 antibody produced in rabbit, affinity isolated antibody
SAB1410759
Anti-LMNB1 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
P7493
Anti-PCAF antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
AV32466
Anti-PCAF antibody produced in rabbit, IgG fraction of antiserum
SAB2101734
Anti-PCAF antibody produced in rabbit, affinity isolated antibody
S5313
Anti-Sir2 (AS-16) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
S5322
Anti-Sirt1 (C-terminal) antibody produced in rabbit, ~1.0 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB1400153
Monoclonal Anti-LMNB1 antibody produced in mouse, clone 4B10, purified immunoglobulin, buffered aqueous solution
SAB1404027
Monoclonal Anti-LMNB1 antibody produced in mouse, clone 4E4, purified immunoglobulin, buffered aqueous solution
WH0008850M2
Monoclonal Anti-PCAF antibody produced in mouse, clone 1H2, purified immunoglobulin, buffered aqueous solution
SAB1404637
Monoclonal Anti-PCAF antibody produced in mouse, clone 5E11, purified immunoglobulin, buffered aqueous solution
SAB1409953
Monoclonal Anti-PCAF antibody produced in mouse, clone 5E5, purified immunoglobulin, buffered aqueous solution
SAB1409954 Monoclonal Anti-PCAF antibody produced in mouse, clone 4C10, purified immunoglobulin, buffered aqueous solution
SAB1409955 Monoclonal Anti-PCAF antibody produced in mouse, clone 4D11, purified immunoglobulin, buffered aqueous solution
SAB1404972
Monoclonal Anti-SIRT1, (C-terminal) antibody produced in mouse, clone 7C2, purified immunoglobulin, buffered aqueous solution